Safety of maralixibat for itching from pregnancy-related liver condition
Treatments studied
Part of Digestive system, Women’s health & pregnancy clinical trials.
This study tests a medication called maralixibat to see if it is safe and well-tolerated in pregnant women with intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching. Participation may help manage your symptoms and provide important information about this potential treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 45 years old.
- You must be pregnant with one baby, between 20 weeks and 35 weeks along.
- You must have a diagnosis of intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching.
- You must be willing to follow the study procedures and sign a consent form.
- You should not have certain liver or pregnancy complications, or have a planned delivery within the next week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called maralixibat for treating intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes severe itching and can affect the baby. The goal is to see if it safely lowers bile acids and improves outcomes for you and your baby.
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
This study looks at bile acid levels and possible genetic changes in people with persistent pregnancy itching. The goal is to better understand the cause of intrahepatic cholestasis of pregnancy and related pregnancy outcomes.
This study tests whether a single injection of esketamine (a pain medicine related to ketamine) given during a cesarean section can reduce itching after the surgery in women with a pregnancy-related liver condition. If it works, it could help you feel more comfortable after your baby is born.
This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.
This study looks at the long-term safety and effects of Livmarli (maralixibat) in children with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC). It may help understand how well the medicine works over time for itching and other symptoms.
Hear when a new Intrahepatic Cholestasis of Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.